Tafinlar is a prescribed medicine. Tafinlar interferes with the growth and spread of cancer cells in the body and is also used to treat certain types of cancer in people who have a ‘BRAF’ gene mutation . It is also used to treat skin cancer (melanoma) , non-small cell lung cancer and thyroid cancer. To buy Tafinlar or to know its price contact 3S Corporation.
Manufacturer :- Novartis Pharmaceuticals Corporation.
Strengths available :- 50 mg and 75 mg
Form :- Capsules
Storage :- Store at 25 ° C
Is the medicine FDA approved :- US FDA Approved
Date of approval :- 29 May , 2013
Dosage :- The recommended dosage regimen of TAFINLAR is 150 mg orally taken twice daily, approximately 12 hours apart as a single agent or with trametinib. Continue treatment until disease progression or unacceptable toxicity occurs.Take TAFINLAR at least 1 hour before or 2 hours after a meal. Do not take a missed dose of TAFINLAR within 6 hours of the next dose of TAFINLAR. Do not open, crush, or break TAFINLAR capsules.
Common side effects of Tafinlar include: squamous cell carcinoma, fever, and hyperglycemia. Other side effects include: keratoacanthom